167
28
14
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T77714 |
HBV-IN-37
|
HBV | Microbiology/Virology |
HBV-IN-37 是一种 HBV 抑制剂,EC50 值为 10 μM,可用于乙型肝炎疾病相关研究。 | |||
T36747 |
HBV-IN-4
|
||
HBV-IN-4, a derivative of phthalazinone, functions as a potent, orally active inhibitor of HBV DNA replication, exhibiting an IC50 value of 14 nM. It effectively induces the formation of genome-free capsids, demonstrating significant anti-HBV potency[1]. | |||
T63079 |
HBV-IN-7
|
||
HBV-IN-6 是一种 HBV 的有效抑制剂 (EC50: 5 nM)。 | |||
T62247 |
HBV-IN-9
|
||
HBV-IN-9 (example 20) 是一种 HBsAg (HBV 表面抗原) 的有效抑制剂,其 IC50 值为 10 nM。HBV-IN-9 (example 20) 也是一种 HBV DNA 复制抑制剂,其 IC50 值为 0.15 nM。 | |||
T62466 |
HBV-IN-17
|
||
HBV-IN-17 (compound 8) 是一种有效的 HBV 衣壳组装调节剂 (EC50: 511 nM)。 | |||
T79879 |
HBV-IN-38
|
HBV | Microbiology/Virology |
HBV-IN-38(实施例 193)作为一种有效的HBVDNA 抑制剂(EC50≤100nM),主要用于研究病毒感染。 | |||
T62579 |
HBV-IN-19
|
||
HBV-IN19 对乙型肝炎病毒 (HBV) 感染具有抑制作用。HBV-IN19 能够抑制 HBsAg 分泌和/或产生,可以用于 HBV 感染的研究 (如:慢性 HBV 感染)。 | |||
T63162 |
HBV-IN-22
|
||
HBV-IN-22 (Compound LC5f) 是一种 HBV DNA 复制抑制剂,作用于野生型 HBV (IC50: 0.71 μM) 和耐药 HBV (IC50: 0.84 μM)。 | |||
T62115 | HBV-IN-24 | ||
HBV-IN-24 (compound (2 S, 6S)-1a) 是一种 HBV 的有效抑制剂。HBV-IN-24 能够较强的抑制 HBV DNA (EC50: 0.6 nM)、HBsAg (EC50: 0.6 nM) 和 HBeAg (EC50: 4.6 nM)。HBV-IN-24 表现出良好的抗病毒效果,能够改善神经毒性。 | |||
T62704 | HBV-IN-23 | ||
HBV-IN-23 (Compound 5k) 是一种 HBV DNA 复制抑制剂 (IC50: 0.58 μM)。HBV-IN-23 能够抑制药物敏感和耐药株。HBV-IN-23 可以诱导 HepG2 细胞凋亡,表现出抗肝癌细胞 (HCC) 效果。 | |||
T62626 | HBV-IN-12 | ||
HBV-IN-12 是一种乙型肝炎表面抗原 (HBsAg) 的有效抑制剂,其 EC50 值大于 0.001 μM 且不大于 0.05 μM。HBV-IN-12 具有抗 HBV DNA 活性,其 EC50 值大于 0.001 μM 且不大于 0.02 μM。 | |||
T79650 |
HBV-IN-40
|
HBV | Microbiology/Virology |
HBV-IN-40(Compound 11826096)是一种具有IC50值为0.7 μM的HBV抑制剂,同时也是一种抗病毒药物。 | |||
T73280 |
HBV-IN-29
|
||
HBV-IN-29 (ex8) 为黄酮衍生物,高效共价抑制闭合环状 DNA (cccDNA),后者为病毒 RNA 转录及病毒 DNA 生成模板。HBV-IN-29 显现出研究HBV感染潜力。 | |||
T63852 |
HBV-IN-8
|
||
HBV-IN-6 是 HBV 的有效抑制剂 (EC50: 287.9 nM)。 | |||
T62467 | HBV-IN-18 | ||
HBV-IN-18 (Compound 3) 是一种 HBV 衣壳组装调节剂 (CpAM) (EC50: 2790 nM)。 | |||
T79767 |
HBV-IN-41
|
HBV | Microbiology/Virology |
HBV-IN-41(化合物45)是一种口服活性乙型肝炎病毒(HBV)抑制剂,具有高效性,其EC50值为0.027μM。 | |||
T73249 |
HBV-IN-15
|
||
HBV-IN-15 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。cccDNA 作为病毒 RNA 转录和随后病毒 DNA 生成的模板。HBV-IN-15 是一种黄酮衍生物。HBV-IN-15 具有研究 HBV 感染的潜力 。 | |||
T73281 |
HBV-IN-30
|
||
HBV-IN-30 (ex44)为黄酮类衍生物,有效抑制共价闭合环状 DNA (cccDNA)。cccDNA在病毒RNA转录及后续病毒DNA合成中作为模板。因此,HBV-IN-30具备研究HBV感染潜力。 | |||
T63795 | HBV-IN-6 | ||
HBV-IN-6 是 HBV 的有效抑制剂 (EC50: 44 nM)。 | |||
T61886 |
HBV-IN-16
|
||
HBV-IN-16 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。cccDNA 作为病毒 RNA 转录和随后病毒 DNA 生成的模板。HBV-IN-16 是一种喹啉衍生物。HBV-IN-16 具有研究 HBV 感染的潜力 。 | |||
T62355 | HBV-IN-14 | ||
HBV-IN-14 是一种吡啶并嘧啶酮类化合物,也是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。其中 cccDNA 是一种病毒 RNA 转录和随后病毒 DNA 生成的模板。HBV-IN-14 具有潜力进行 HBV 感染的研究。 | |||
T73282 |
HBV-IN-31
|
||
HBV-IN-31 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。HBV-IN-31 具有抗HBV 活性,对 HBsAg 的 IC50值为 0.13 µM。HBV-IN-31 抑制细胞生长。 | |||
T62256 | HBV-IN-11 | ||
HBV-IN-11 是一种有效的 HBsAg 分泌抑制剂 (EC50: 0.46 μM)。 | |||
T64260 | HBV-IN-20 | ||
HBV-IN-20 是一种有效的、口服具有活力的 HBV 抑制剂 (EC50: 0.46 μM)。HBV-IN-20 是一种典型的 II 型 CpAM (核心蛋白组装调节剂)。 | |||
T61558 |
HBV-IN-21
|
||
HBV-IN-21 (Compound II-8b) is a potent inhibitor of HBV DNA replication, exhibiting an IC50 of 2.2 μM. It demonstrates a favorable binding affinity (K D = 60.0 μM) for the HBV 4 capsid protein, thereby enabling effective interaction [1]. | |||
T78783 |
HBV-IN-35
|
HBV | Microbiology/Virology |
HBV-IN-35(Compound 88)是具有对小鼠和人肝细胞中HBV抗病毒活性的抑制剂,其EC50值分别为100 nM和400 nM。 | |||
T79469 | HBV-IN-34 | HBV | Microbiology/Virology |
HBV-IN-34(化合物17i)是一款抗HBV药物,可以有效抑制HBsAg的生成。在体外实验中,HBV-IN-34对HBVDNA和HBsAg的EC50值分别为0.018 μM和0.044 μM,显示出卓越的抗病毒活性。 | |||
T78812 |
HBV-IN-36
|
HBV | Microbiology/Virology |
HBV-IN-36(compound 42)是一种抗乙型肝炎病毒(HBV)活性显著的化合物,其抑制剂效力(IC50=2 μM)以及EC50值为0.85 μM,表明其作为HBV抑制剂具有潜在的临床应用价值。 | |||
T73283 | HBV-IN-32 | ||
HBV-IN-31 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。HBV-IN-31 具有抗HBV 活性,对 HBsAg 的 IC50值为 0.14 µM。HBV-IN-31 抑制细胞生长。 | |||
T61115 |
HBV-IN-25
|
||
HBV-IN-25 is a novel chemical compound that acts as a potent HBV cccDNA reducer when administered orally. It exhibits significant anti-HBeAg potency and anti-HBV activity, with IC50 values of 0.58 μM and 1.15 μM, respectively. Moreover, HBV-IN-25 demonstrates favorable aqueous solubility (LYSA>452 μg/mL) and no cellular toxicity, making it a promising candidate for further investigation and development [1]. | |||
T62144 | HBV-IN-13 | ||
HBV-IN-12 是一种乙型肝炎表面抗原 (HBsAg) 的有效抑制剂。 | |||
T62434 |
HBV-IN-10
|
||
HBV-IN-10 是一种 compound 6 (WO2021204258A1) 的异构体。其中 Compound 6 是一种乙型肝炎表面抗原 (HBsAg) 的有效抑制剂 (0.1 μM< EC50≤1 μM)。 | |||
T63937 |
HBV-IN-19 TFA
|
||
HBV-IN19 TFA 能够抑制 HBsAg 分泌和/或产生,并对乙型肝炎病毒 (HBV) 感染具有抑制作用,能够用于 HBV 感染 (包括慢性 HBV 感染) 的研究。 | |||
T76532 |
HBV Seq1 aa:93-100
|
||
HBVSeq1 aa:93-100 是乙型肝炎病毒 (HBV) 核心抗原 93-100 肽片段。 | |||
T76529 |
HBV Seq2 aa:28-39
|
||
HBVSeq2 aa:28-39 是一种 HBsAg 肽,可与主要组织相容性复合体 (MHC) I 类分子结合。 | |||
T76534 |
HBV Seq1 aa:18-27
|
||
HBVSeq1 aa:18-27 是乙型肝炎病毒 (HBV) 核心抗原 18-27 肽片段。 | |||
T76530 |
HBV Seq2 aa:208-216
|
||
HBVSeq2 aa:208-216,作为HBsAg衍生的CD8表位肽,是乙型肝炎病毒大包膜蛋白一部分,目前正被研究。 | |||
T76531 |
HBV Seq2 aa:179-186
|
||
HBVSeq2 aa:179-186 作为 H-2b 系统中 CTL 反应的有效基序,能在体外再刺激致敏 T 细胞后发挥作用,同时被认为是鉴定乙型肝炎病毒表面抗原的新表位。 | |||
T62433 | (5S,8R)-HBV-IN-10 | ||
(5S,8R)-HBV-IN-10 是一种 compound 6 (WO2021204258A1) 的异构体。其中 Compound 6 是一种乙型肝炎表面抗原 (HBsAg) 的有效抑制剂 (0.1 μM< EC50≤1 μM)。 | |||
T76535 |
HBV Seq1 aa:141-151
|
||
HBVSeq1 aa:141-151 是一种肽。HBVSeq1 aa:141-151 可用于慢性乙型肝炎病毒(HBV)的研究。 | |||
T5832 |
Besifovir
|
HBV | Microbiology/Virology |
Besifovir 是由 LB80380 转化而来的一种 LB80380 母体药物,进一步代谢为其活性形式 LB80317。LB80380 是抗乙型肝炎病毒的抗病毒药物。 | |||
T76533 |
HBV Seq1 aa:63-71
|
||
HBVSeq1 aa:63-71 是乙型肝炎病毒 (HBV) 的片段。 | |||
TQ0017 |
AB-423
|
HBV | Microbiology/Virology |
AB-423 是一种 HBV 衣壳组装抑制剂,抑制 HBV 复制。在细胞中,EC50/EC90值分别为 0.08-0.27 μM/0.33-1.32 μM。 | |||
T4475 |
JNJ-632
|
HBV | Microbiology/Virology |
JNJ-632 是一种乙型肝炎病毒衣壳组装调节剂。 | |||
T20048 |
Vidarabine phosphate
|
Antiviral | Immunology/Inflammation |
Vidarabine phosphate 是一种单磷酸腺苷类似物。它是 VIDARABINE 的单磷酸酯。它还具有抗病毒和可能的抗肿瘤特性。 | |||
T11409 |
GLP-26
|
HBV | Microbiology/Virology |
GLP-26 是一种HBV 衣壳组装调节剂,抑制 Hep AD38 系统中的 HBV DNA 复制,IC50值为3 nM。 在 1 μM 时,使 cccDNA 降低> 90%。它破坏前基因组 RNA 的衣壳化,导致核衣壳解体,并减少 cccDNA 库。 | |||
T9225 |
Vebicorvir
ABI-H0731 |
HBV | Microbiology/Virology |
Vebicorvir (ABI-H0731) 是一种乙型肝炎病毒核心蛋白的抑制剂,有抗病毒活性。 | |||
T3449 |
Bay 41-4109 racemate
|
HBV | Microbiology/Virology |
BAY 41-4109 racemate 是BAY 41-4109的消旋体。BAY 41-4109有效抑制人乙型肝炎病毒,IC50值为53 nM。 | |||
T7447 |
Adefovir
|
HBV; Reverse Transcriptase; Telomerase | DNA Damage/DNA Repair; Microbiology/Virology |
Adefovir 是一种单磷酸腺苷类似物抗病毒剂,在细胞内转化为 Adefovir diphosphate 后可抑制HBVDNA 聚合酶。它在 HepG2.2.15 细胞系中对HBV 的IC50为 0.7 μM。它对多种病毒(包括HBV 和疱疹病毒)具有良好的抗病毒活性。 | |||
T11669 |
IR415
|
HBV | Microbiology/Virology |
IR415 选择性地与 HBx 相互作用 (Kd=2 nM) 并阻断 HBV 介导的 RNAi 抑制,逆转 HBx 蛋白对 Dicer 核糖核酸内切酶活性的抑制作用。IR415 具有抗 HBV 的活性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1482 |
Chamaechromone
|
P450; HBV | Metabolism; Microbiology/Virology |
Chamaechromone 是从 Stellera chamaejasme L. 的根中分离出来的天然产物。 Chamaechromone 具有抗 HBV 和杀虫活性。 | |||
T4S1718 |
Punicalin
|
HBV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Punicalin 是从Punica granatumL. 或Terminalia catappaL. 的叶子中分离的,一种可水解的单宁,具有抗炎活性。它是一种抗乙型肝炎病毒药物。 | |||
T3S0872 |
Paederoside
|
Antiviral; HBV | Immunology/Inflammation; Microbiology/Virology |
Paederoside 是从Paederia pertomentosa 分离的一种单萜 S-甲基硫代碳酸酯。它抑制 Epstein-Barr 病毒的激活,有抗肿瘤促进作用。 | |||
TQ0248 |
Alisol F
泽泻醇 F,泽泻醇F |
HBV | Microbiology/Virology |
Alisol F 是从泽泻中分离得到的一种三萜,具有免疫抑制和抗病毒功能。 | |||
T3273 |
Bifendate
联苯双酯,Bifendatatum |
HBV; Reverse Transcriptase | Microbiology/Virology |
Bifendate (Bifendatatum) 是 Schisandrin C 的合成中间体,在慢性 B 型肝炎的研究中具有抗HBV 功效,用于治疗病毒性肝炎和药物性肝损伤引起的转氨酶升高。 | |||
T2780 |
Catalpol
梓醇,Catalpinoside,Digitalis purpurea L |
Others; HBV | Microbiology/Virology; Others |
Catalpol (Catalpinoside) 是一种在Rehmannia glutinosa 中发现的鸢尾花苷,具有神经保护、降血糖、抗癌、抗痉挛、抗氧化、抗HBV 和抗肝炎病毒作用。 | |||
T1922 |
Pseudolaric Acid B
土槿乙酸B,土荆皮乙酸 |
Apoptosis; p38 MAPK; Ferroptosis; HBV; Autophagy; Antifungal | Apoptosis; Autophagy; MAPK; Microbiology/Virology |
Pseudolaric Acid B 是一种从Pseudolarix kaempferiGorden (pinaceae) 根部分离的二萜酸,具有抗癌、抗真菌、抗受精和免疫抑制活性。它还诱导细胞自噬。 | |||
T5S2254 |
Swertianolin
Bellidifolin-8-O-Glucoside,当药醇苷 |
Others; HBV; Antibacterial; AChE | Microbiology/Virology; Neuroscience; Others |
Swertianolin (Bellidifolin-8-O-Glucoside) 是从Gentianella Acuta 分离得到的一种黄酮,具有抗 HBV 和抗菌活性,可抑制乙酰胆碱酯酶。 | |||
T3921 |
Punicalagin
安石榴甙,安石榴苷 |
SARS-CoV; HBV | Microbiology/Virology |
Punicalagin 是一种在石榴中发现的主要鞣花单宁,是可逆且非竞争性的3CLpro 抑制剂,有抗氧化、抗炎和抗癌作用。它有潜力研究 COVID-19 。 | |||
T3815 |
Isoscopoletin
异莨菪亭,7-Methoxyesculetin,6-Hydroxy-7-methoxycoumarin |
Others; HBV | Microbiology/Virology; Others |
Isoscopoletin (7-Methoxyesculetin) 是艾叶中的一种活性成分。它具有显著的细胞增殖抑制作用,对人类 CCRF-CEM 白血病细胞和耐药亚系 CEM/ADR5000 作用的 IC50值分别为 4.0 μM 和 1.6 μM。它具有抑制 HBV 复制的活性。 | |||
T2848 |
Osthole
Osthol,NSC 31868,蛇床子素,Ostol |
Apoptosis; HBV; Parasite; Histamine Receptor | Apoptosis; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience |
Osthole (Osthol) 是一种天然抗组胺药替代试剂,可刺激成骨细胞增殖和分化。它可抑制组胺 H1受体活性,还可抑制细胞培养物中 HBV 的分泌。 | |||
T5098 |
Isochlorogenic acid A
3,5-CQA,异绿原酸 A,3,5-Dicaffeoylquinic acid,金银花 |
Reactive Oxygen Species; HBV; Endogenous Metabolite | Immunology/Inflammation; Metabolism; Microbiology/Virology; NF-κB |
Isochlorogenic acid A (3,5-Dicaffeoylquinic acid) 是一种天然酚酸,具有抗氧化和抗炎活性。 | |||
T3750 |
4-Hydroxyacetophenone
对羟基苯乙酮,4-Acetylphenol,Piceol,p-Acetylphenol,4'-Hydroxyacetophenone |
HBV; Xanthine Oxidase | Metabolism; Microbiology/Virology |
4-Hydroxyacetophenone (4-Acetylphenol) 是蒿属植物和木香属植物中的一种黄嘌呤氧化酶抑制剂,具有保肝促胆、抗乙型肝炎病毒和抗炎作用。 | |||
T2S1158 |
4,5-Dicaffeoylquinic acid
3,4-Dicaffeoylquinic acid,异绿原酸C(4,5),Isochlorogenic acid C |
Others; HBV; Endogenous Metabolite | Metabolism; Microbiology/Virology; Others |
4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) 是一种天然产物,有抗病毒、抗肝毒性活性。 | |||
T0894 |
Thiamine hydrochloride
盐酸硫胺素,Vitamin B1,Vitamin B1 hydrochloride,Thiamine HCl,盐酸硫胺(维生素B1),Thiamine chloride hydrochloride |
Apoptosis; HBV; Endogenous Metabolite | Apoptosis; Metabolism; Microbiology/Virology |
Thiamine hydrochloride (Vitamin B1) 是一种必需的微量营养素,是许多中枢代谢酶的辅因子。 | |||
T1020 |
Doxorubicin hydrochloride
Adriamycin,Doxorubicin (Adriamycin) HCl,Hydroxydaunorubicin hydrochloride,盐酸多柔比星,盐酸阿霉素,NSC 123127 |
Apoptosis; Mitophagy; HBV; HIV Protease; Topoisomerase; Antibacterial; Antibiotic; AMPK; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Doxorubicin hydrochloride (Adriamycin) 属于蒽环类抗生素,是人类 DNA 拓扑异构酶 I/II 抑制剂 (IC50=0.8/2.67 μM)。Doxorubicin hydrochloride 具有细胞毒性和抗肿瘤活性。Doxorubicin hydrochloride 可降低 AMPK 及其下游靶蛋白乙酰辅酶 A 羧化酶的磷酸化,还可诱导凋亡和自噬。 | |||
T1456 |
Doxorubicin
Hydroxydaunorubicin,阿霉素,Adriamycin |
Topoisomerase; AMPK | Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
Doxorubicin (Adriamycin) 是一种有细胞毒性的蒽环类抗生素,具有肿瘤化疗作用。它抑制DNA 拓扑异构酶 I 和拓扑异构酶 II,IC50分别为0.8 μM 和2.67 μM,从而抑制 DNA 复制。它下调AMPK 的基础磷酸化以及下游 acetyl-CoA 羧化酶。它诱导凋亡和自噬 。 | |||
TN5845 |
Neochlorogenic acid methyl ester
5-O-Caffeoylquinic acid methyl ester,Methyl 3-caffeoylquinate,GIP (1-39) acetate(725474-97-5 Free base),Methyl neochlorogenate,新绿原酸甲酯 |
Antioxidant; HBV | Microbiology/Virology; oxidation-reduction |
Neochlorogenic acid methyl ester (5-O-Caffeoylquinic acid methyl ester) 来源于毛蒿和黑色苦莓(Aronia melanocarpa)果实。Neochlorogenic acid methyl ester 显示出抗 HBV 活性、抗氧化活性和醌还原酶活性,CD 为 6.7 μM。 | |||
T3794 |
Pentagalloylglucose
Penta-O-galloyl-β-D-glucose,1,2,3,4,6-O-Pentagalloylglucose,1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose,1,2,3,4,6-五没食子酰葡萄糖 |
Influenza Virus | Microbiology/Virology |
1,2,3,4,6-O-Pentagalloylglucose (Penta-O-galloyl-β-D-glucose) 存在于多种植物中,具有重要的药理作用。Pentagalloylglucose 表现出显著的抗狂犬病病毒 (RABV) 活性。 | |||
T79975 |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside
|
HBV | Microbiology/Virology |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside(化合物1)是一种具有抗HBV活性的木脂素类化合物。该化合物对HBV表面抗原(HBsAg)的IC50为0.58 mM,而对HBV e抗原(HBeAg)的IC50 > 2.4 mM。其可从八角茴香中提取分离。 | |||
TN2188 |
Schisanwilsonin B
Schisanwilsonin I,鹤庆五味子素 B |
Others | Others |
Schisanwilsonin D, and schisantherin C show anti-HBV activity. | |||
TN1732 | Herpetone | HBV | Microbiology/Virology |
Herpetone exhibits protective effects on CCl(4)-induced hepatocyte injury, it shows anti-hepatitis B virus (HBV) activity. | |||
T79976 |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside
|
HBV | Microbiology/Virology |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside 作为一种抗HBV剂,在Hep G2.2.15细胞系上能够抑制HBsAg和HBeAg的分泌,其IC50值分别约为1.67 mM和>2.15 mM。 | |||
T81531 |
Pedunculosumoside F
|
||
Pedunculosumoside F,一种从Ophioglossum pedunculosum分离得到的同型黄酮苷,对HepG2 2.2.15细胞表现出细胞毒性,其CC50值为56.7 μM,但缺乏抗HBV活性。然而,其类似物能够抑制HBV感染的HepG2 2.2.15细胞中HBsAg的分泌。 | |||
TN2220 |
Sophoranol
槐醇,(+)-Sophoranol |
HBV | Microbiology/Virology |
(+)-Sophoranol exhibits antiviral activity against the Coxsackie virus B3. It also shows potent anti-HBV activity with an inhibitory potency against HBsAg secretion and against HBeAg secretion. | |||
TN4750 |
Periglaucine A
|
HBV | Microbiology/Virology |
Periglaucine A inhibits hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. | |||
TN3687 |
Coclauril
|
HBV | Microbiology/Virology |
Coclauril shows anti-Hepatitis B virus (HBV) activities, with EC50 values of 7.6 ± 0.5 ug/mL. | |||
TN4751 |
Periglaucine B
|
HBV | Microbiology/Virology |
Periglaucine B can inhibit hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-01492 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi)
Hepatitis B virus,HBV,MHC |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01501 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi)
MHC,Hepatitis B virus,HBV |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01491 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,HBV,Hepatitis B virus |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPY-05822 |
Hepatitis B Virus (HBV)(ayw/France/Tiollais/1979) Capsid protein (His)
|
HBV-D | E. coli |
Hepatitis B virus (HBV) capsid assembly is a critical step in the propagation of the virus and is mediated by the core protein. The first cytoplasmic step in the formation of an infectious HBV virion is the formation of a capsid containing pregenomic RNA (pgRNA) and the viral polymerase (Pol). HBV capsid assembly is an attractive target for new antiviral therapies. | |||
TMPH-00803 |
HBV-A subtype adw2 (strain Rutter 1979) Capsid protein (His)
|
HBV-A | E. coli |
HBV-A subtype adw2 (strain Rutter 1979) Capsid protein (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 25.4 kDa and the accession number is P03148. | |||
TMPH-00806 |
HBV-D (isolate Germany/1-91/1991) Protein X (His & SUMO)
|
HBV-D | E. coli |
HBV-D (isolate Germany/1-91/1991) Protein X (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 32.7 kDa and the accession number is O93195. | |||
TMPH-00807 |
HBV-D subtype ayw (isolate France/Tiollais/1979) Protein X (His & SUMO)
|
HBV-D | E. coli |
HBV-D subtype ayw (isolate France/Tiollais/1979) Protein X (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 32.6 kDa and the accession number is P03165. | |||
TMPH-00816 |
HBV-A subtype adw2 (strain Rutter 1979) Large envelope protein (His)
|
HBV-A | E. coli |
HBV-A subtype adw2 (strain Rutter 1979) Large envelope protein (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 45.1 kDa and the accession number is P03141. | |||
TMPH-00808 |
HBV-D subtype ayw (isolate Japan/JYW796/1988) Protein X (His)
|
HBV-D | E. coli |
HBV-D subtype ayw (isolate Japan/JYW796/1988) Protein X (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 22.6 kDa and the accession number is Q9QMI3. | |||
TMPH-00815 |
HBV-A subtype adw2 (isolate Germany/991/1990) Capsid protein (His & Myc)
|
HBV-A | E. coli |
HBV-A subtype adw2 (isolate Germany/991/1990) Capsid protein (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 28.9 kDa and the accession number is P0C693. | |||
TMPH-00804 |
HBV-C subtype ayw (isolate China/Tibet127/2002) Capsid protein (Yeast, His)
|
HBV-C | P. pastoris (Yeast) |
HBV-C subtype ayw (isolate China/Tibet127/2002) Capsid protein (Yeast, His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 23.0 kDa and the accession number is P0C6H7. | |||
TMPH-00805 |
HBV-C subtype ayw (isolate China/Tibet127/2002) Capsid protein (E. coli, His)
|
HBV-C | E. coli |
HBV-C subtype ayw (isolate China/Tibet127/2002) Capsid protein (E. coli, His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 27.1 kDa and the accession number is P0C6H7. | |||
TMPY-02193 |
GOLPH2/GOLM1 Protein, Human, Recombinant (His)
HEL46,PSEC0257,GOLPH2,bA379P1.3,C9orf155,GP73,golgi membrane... |
Human | HEK293 Cells |
Golgi membrane protein 1, also known as Golgi membrane protein GP73, Golgi phosphoprotein 2, and GOLM1, is a protein that belongs to the GOLM1 / CASC4 family. GOLM1 is widely expressed. It is highly expressed in the colon, prostate, trachea, and stomach. It is expressed at a lower level in testis, muscle, lymphoid tissues, white blood cells, and spleen. It is predominantly expressed by cells of the epithelial lineage. GOLM1 is expressed at a low level in the normal liver. Expression significantl... | |||
TMPY-04567 |
SRPK1 Protein, Human, Recombinant (His & GST)
SRSF protein kinase 1,SFRSK1,RP3-422H11.1 |
Human | Baculovirus Insect Cells |
Serine / threonine-protein kinase SRPK1, also known as SFRS protein kinase 1, Serine/arginine-rich protein-specific kinase 1, SR-protein-specific kinase 1 and SRPK1, is a cytoplasm and nucleus protein that belongs to the protein kinase superfamily and CMGC Ser/Thr protein kinase family. Isoform 2 of SRPK1 is predominantly expressed in the testis but is also present at lower levels in heart, ovary, small intestine, liver, kidney, pancreas and skeletal muscle. Isoform 1 of SRPK1 is only seen in th... |